Results 61 to 70 of about 1,511,556 (290)

Sensitivity and specificity plots.

open access: yes, 2016
To determine the optimal cut-off point, sensitivity and specificity are plotted against the threshold (A), the optimal cut-off point is present at 0.52. The sensitivity is plotted against 1—specificity for all cutoff values of the PLS-DA model in the ROC
Danique Vervoort (2822603)   +4 more
core   +1 more source

Summary of findings: Sensitivity and specificity.

open access: yes, 2022
Summary of findings: Sensitivity and specificity.
Advaith Gummaraju (13007355)   +7 more
core   +1 more source

Grader agreement, and sensitivity and specificity of digital photography in a community optometry-based diabetic eye screening program

open access: yesClinical Ophthalmology, 2014
Luckni Sellahewa,1,2 Craig Simpson,2 Prema Maharajan,2 John Duffy,2 Iskandar Idris3 1Diabetic Medicine Department, Nottingham University Hospitals, 2North Nottinghamshire Eye Screening Service, Sherwood Forest Hospitals Foundation Trust, 3Division of ...
Sellahewa L   +4 more
doaj  

Accuracy of the Applied Kinesiology Muscle Strength Test for Sacroiliac Dysfunction [PDF]

open access: yesRevista Brasileira de Ortopedia
Objective To investigate the accuracy of the applied kinesiology muscle strength test for sacroiliac dysfunction and compared it with four validated orthopedic tests.
Jaisson Agne Estrázulas   +5 more
doaj   +3 more sources

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Neurocognitive, School‐Based, and Quality of Life Outcomes for Youth With Sickle Cell Disease and Thalassemia: A Scoping Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT The medical burdens of sickle cell disease (SCD) and transfusion‐dependent β‐thalassemia (TDT) are chronic and cumulative, even in children. Yet the effects expand beyond medications and healthcare visits due to their impacts on school attendance, academic performance, and peer engagement.
Mary Ann Etling   +2 more
wiley   +1 more source

Comparison for sensitivity and specificity

open access: yes, 2015
Comparison for sensitivity and ...
Kamran Shah (799893)   +4 more
core   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola   +4 more
wiley   +1 more source

Sensitivity and specificity of fractures.

open access: yes, 2019
Sensitivity and specificity of fractures.
Jakob Neubauer (3279204)   +9 more
core   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy